Regulation of Cell Growth and Virulence Gene Expression in Staphylococcus aureus by the Iron-Binding Proteins Lactoferrin and Hemin
Article Sidebar
Main Article Content
Abstract
Staphylococcus aureus is a leading cause of nosocomial infections in the United States, particularly in immune-suppressed patients and preterm infants. S. aureus requires free iron in its environment to thrive and reproduce. In mammals, free iron is sequestered away from pathogens by iron-binding proteins, including hemoglobin and lactoferrin. Lactoferrin has bacteriostatic properties and was shown in randomized controlled clinical trials and subsequent meta-analysis to reduced S. aureus septicemia in preterm infants. Herein, we tested the hypothesis that lactoferrin would reduce the growth of S. aureus in vitro and modulate the expression of iron-regulated surface determinate (Isd) proteins, which are used by S. aureus to cleave heme from the host’s hemoglobin, and gyrA, a marker of cell oxidative stress. S. aureus S54F9 cells were cultured in sow serum in the absence (control; Ctrl) or presence of subphysiological (1 μM), physiological (3 μM), or superphysiological (6 μM) serum concentrations of hemin (HM), lactoferrin (LF), and both proteins (Cmb). Cell growth was assessed every 12 hr. by optical density and cells were harvested after 96 hr. to assess mRNA expression of IsdG, IsdC, and gyrA. LF at both 3 μM and 6 μM and Cmb at 6 μM inhibited cell growth compared to Ctrl. LF and Cmb at 6 μM increased mRNA expression of IsdG and gyrA supporting bacterial adaptations in response to iron sequestration. These findings suggest potential mechanisms whereby lactoferrin prevents S. aureus infection in clinical settings.
Article Details
References
Ağca H, Topaç T, Özmerdiven GE, Celebi S, Köksal N, Hacimustafaoğlu M, Cilo BD, Sinirtas M, Özakin C (2014) Investigation of methicillin resistant Staphylococcus aureus in neonatal intensive care unit. International Journal of Clinical & Experimental Medicine 7:2209-2213
Aligholi M, Mirsalehian A, Halimi S, Imaneini H, Jabalameli F, Asadollahi P, Mohajer B, Abdollahi, Emaneini M (2011) Phenotypic and genotypic evaluation of fluoroquinolone resistance in clinical isolates of Staphylococcus aureus in Tehran. Medical Science Monitor 17:71-75
Arnold RR. Brewer M, Gauthier JJ (1980) Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infection & Immunity 28:893-898
Artym J, Zimecki M, Kruzel ML (2004) Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin. International Immunopharmacology 4:1149–1157
Atshan SS, Shamsudin MN, Karunanidhi A, van Belkum A, Lung LTT, Sekawi Z, Nathan JJ, Ling KH, Seng JSC, Ali AM, Abdujaleel SA, Hamat RA (2013) Quantitative PCR analysis of genes expressed during biofilm development of methicillin resistant Staphylococcus aureus (MRSA). Infection, Genetics & Evolution 18:106-112
Chen P-W, Jheng TT, Shyu C-L, Mao FC (2013) Antimicrobial potential for the combination of bovine lactoferrin or its hydrolysate with lactoferrin-resistant probiotics against foodborne pathogens. Journal of Dairy Science 96:1438-1446
Donlan RM, Costerton JW (2002) Biofilms: Survival mechanisms of clinically significant microorganisms. Clinical Microbiology Reviews 15:167-193
Farnaud S, Evans RW (2003) Lactoferrin–a multifunctional protein with antimicrobial properties. Molecular Immunology 40:395-405
Harada E, Itoh Y, Sitizyo K, Takeuchi T, Araki Y, Kitagawa H (1999) Characteristic transport of lactoferrin from the intestinal lumen into the bile via the blood in piglets. Comparative Biochemistry & Physiology Part A: Molecular & Integrative Physiology 124:321-327
Hornik CP, Fort P, Clark RH, Watt K, Benjamin Jr. DK, Smith PB, Manzoni P, Jacqz-Algrain E, Kaguelidou F, Cohen-Wolkowiez M (2012) Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Human Development 88 (Supplement 2):S69-S74
Jaktaji RP, Mohiti E (2010) Study of mutations in DNA gyrase gyrA gene in Escherichia coli. Iranian Journal of Pharmaceutical Research 9:43-48
Kaplan JB (2010) Biofilm dispersal: Mechanisms, clinical implications, and potential therapeutic uses. Journal of Dental Research 89:205-218
Kapoor R, Barnett CJ, Gutmann RM, Yildiz, VO, Joseph NC, Stoicea N, Reyes S, Rogers BM (2014) Preoperative prevalence of Staphylococcus aureus in cardiothoracic and neurological surgical patients. Frontiers in Public Health 2:1-4
Lin L, Pantapalangkoor P, Tan B, Bruhn KW, Ho T, Nielsen T, Skaar EP, Zhang Y, Bal R, Wang A, Doherty TM, Spellberg B (2014) Transferrin iron starvation therapy for lethal bacterial and fungal infections. Journal of Infectious Diseases 210:254-264
Mazmanian SK, Skaar EP, Gaspar AH, Humayun M, Gornicki P, Jelenska J, Joachmiak A, Missiakas DM, Schneewind O (2003) Passage of heme-iron across the envelope of Staphylococcus aureus. Science 293:906-909
Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. New England Journal of Medicine 355:666-675
Moriwaki, Y, Terada T, Caaveiro JMM, Takaoka Y, Hamachi I, Tsumoto K, Shimizu K (2013) Heme binding mechanism of structurally similar iron-regulated surface determinant near transporter domains of Staphylococcus aureus exhibiting different affinities for heme. Biochemistry 52:8866-8877
Nielsen OL, Iburg T, Aalbaek B, Leifsson PS, Agerholm JS, Heegaard P, Boye M, Simon S, Jensen KB, Christensen S, Melsen K, Bak AK, Backman ER, Jørgensen, MH, Groegler DK, Jensen AL, Kjelgaard-Hansen M, Jensen HE (2009) A pig model of acute Staphylococcus aureus induced pyemia. Acta Veterinaria Scandinavica 51:14
Oogai Y, Matsuo M, Hashimoto M, Kato F, Sugai M, Komatsuzawa H (2011) Expression of virulence factors by Staphylococcus aureus grown in serum. Applied & Environmental Microbiology 77:8097-8105
Pammi M, Abrams SA (2015) Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews, Article Number CD007137, doi: 10.1002/14651858.CD007137.pub4
Radtke A., O’Riordan MXD (2006) Intracellular innate resistance to bacterial pathogens. Cellular Microbiology 8:1720-1729
Schröder W, Bernhardt J. Marincola G, Klein-Hitpass L, Herbig A, Krupp G, Nieselt K, Wolz C (2014) Altering gene expression by aminocoumarins: the role of DNA supercoiling in Staphylococcus aureus. BMC Genomics 15: 291
Shane AL, Hansen NI, Stoll BJ, Bell EF, Sánchez PJ, Shankaran S, Laptook AR, Das A, Walsh MC, Hale EC, Newman NS, Schrag SJ, Higgins RD and the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (2012) Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants. Pediatrics 29:e914-e922
Skaar EP, Gasper AH, Schneewind O (2003) IsdG and IsdI, heme-degrading enzymes in the cytoplasm of Staphylococcus aureus. The Journal of Biological Chemistry 279:436-443
Skaar EP (2010) The battle for iron between bacterial pathogens and their vertebrate hosts. PLOS Pathogens 6:e1000949, doi: 10.1371/journal.ppat.1000949
Spirig T, Malmirchegini GR, Zhang J, Robson SA, Sjodt M, Liu M, Kumar KK, Dickson CF, Gell DA, Lei B, Loo JA, Clubb RT (2013) Staphylococcus aureus uses a novel multidomain receptor to break apart human hemoglobin and steal its heme. The Journal of Biological Chemistry 288:1065-1078
Stoll BJ (2004) Infections of the neonatal infant. Pages 623–640 In: Behrman RE, Kliegman R, Jenson HB (eds) Nelson’s Textbook of Pediatrics. 17th Edition. Saunders: Philadelphia
Stoll BJ, Hansen N, Fanaroff AA, Wright LL. Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK. (2002) Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network. Pediatrics 110:285–291
Stoll BJ, Hansen, NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, Laptook A, Walsh M, Oh W, Hale E (2005) Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram negative infections continues in the NICHD Neonatal Research Network, 2002-2003. The Pediatric Infectious Disease Journal 24635–639
Venkatesh MP, Pham D, Kong L, Weisman L (2007) Prophylaxis with lactoferrin, a novel antimicrobial agent, in a neonatal rat model of coinfection. Advances in Therapy 24:941–954
Zagulski T, Lipinski P, Zagulska A, Broniek S, Jarzabek Z (1989) Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. British Journal of Experimental Pathology 70:697-704